ctrl K

BioPlus Acquisition Corp. (BIOSU)

NASDAQ: BIOSU · Real-Time Price · USD

10.80

-0.04 (-0.37%)

At close: Oct 06, 2023, 7:59 PM

BioPlus Acquisition Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	140.3K	635.54K	14.5M	39.5M	9.6M
Short-Term Investments	237.78M	n/a	n/a	n/a	n/a
Long-Term Investments	237.78M	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	234.98M	2.7M	2.1M	-100K
Receivables	n/a	n/a	114.9M	85.5M	111.8M
Inventory	n/a	n/a	26.7M	38M	36.2M
Other Current Assets	408.46K	366.74K	18.6M	24.7M	18.5M
Total Current Assets	548.76K	1M	174.7M	187.7M	176.1M
Property-Plant & Equipment	n/a	n/a	28.8M	27M	32.5M
Goodwill & Intangibles	n/a	n/a	377.7M	386.3M	396.9M
Total Long-Term Assets	237.78M	234.98M	409.2M	415.4M	431.6M
Total Assets	238.32M	235.98M	583.9M	603.1M	607.7M
Account Payables	n/a	n/a	67M	66M	59.1M
Deferred Revenue	408.46K	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	526.88K	179.14K	40.3M	39.1M	71.3M
Total Current Liabilities	526.88K	179.14K	107.3M	105.1M	130.4M
Long-Term Debt	5M	5M	501.5M	478.9M	433.4M
Other Long-Term Liabilities	9.8M	9.8M	460.4M	21.8M	377.8M
Total Long-Term Liabilities	14.8M	14.8M	527.4M	500.7M	436.9M
Total Liabilities	15.33M	14.98M	634.7M	605.8M	567.3M
Total Debt	5M	5M	504.7M	480.6M	451.9M
Common Stock	237.78M	234.6M	n/a	n/a	n/a
Retained Earnings	-14.78M	-13.6M	-761.2M	-709.5M	-643.4M
Comprehensive Income	n/a	n/a	-100.9M	-88.3M	-75.1M
Shareholders Equity	223M	221M	-50.7M	-2.7M	40.4M
Total Investments	237.78M	n/a	n/a	n/a	n/a